WELCOME

StatFinn and EPID Research merged their operations in January 2017 and as one company offer a full range of services in Clinical Trial Biostatistics, Data Management, Epidemiology and Real-World Evidence that covers the drug development life cycle - from Phase I to Phase IV and beyond.

Please select the website that you want to visit: